John M Robertson

Summary

Affiliation: William Beaumont Hospital
Country: USA

Publications

  1. doi request reprint Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 82:e187-92. 2012
  2. doi request reprint Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model
    John M Robertson
    William Beaumont Hospital, Department of Radiation Oncology, Royal Oak, Michigan 48073, USA
    Int J Radiat Oncol Biol Phys 77:66-72. 2010
  3. ncbi request reprint The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 70:413-8. 2008
  4. doi request reprint The role of radiation therapy for colorectal cancer
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, 3601 West Thirteen Mile Road, Royal Oak, MI 48073, USA
    Gastroenterol Clin North Am 37:269-85, ix. 2008
  5. doi request reprint Generic planning target margin for rectal cancer treatment setup variation
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 74:1470-5. 2009
  6. doi request reprint Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma
    Jiayi Huang
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    Int J Radiat Oncol Biol Phys 83:1120-5. 2012
  7. doi request reprint Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer
    Jiayi Huang
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, USA
    Radiother Oncol 99:114-9. 2011
  8. ncbi request reprint The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer
    Joost J Nuyttens
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    Cancer Radiother 8:297-304. 2004
  9. ncbi request reprint The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer
    Kathy L Baglan
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 52:176-83. 2002
  10. doi request reprint Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine
    Andrew Baschnagel
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan 48072, USA
    Int J Radiat Oncol Biol Phys 83:e331-5. 2012

Collaborators

Detail Information

Publications16

  1. doi request reprint Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 82:e187-92. 2012
    ..To determine the recommended dose of radiotherapy when combined with full-dose gemcitabine and erlotinib for unresected pancreas cancer...
  2. doi request reprint Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model
    John M Robertson
    William Beaumont Hospital, Department of Radiation Oncology, Royal Oak, Michigan 48073, USA
    Int J Radiat Oncol Biol Phys 77:66-72. 2010
    ..Understanding the dose-volume relationship of small bowel irradiation and severe acute diarrhea may help reduce the incidence of this side effect during adjuvant treatment for rectal cancer...
  3. ncbi request reprint The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 70:413-8. 2008
    ..This study tested the previously defined parameters in a much larger group of patients...
  4. doi request reprint The role of radiation therapy for colorectal cancer
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, 3601 West Thirteen Mile Road, Royal Oak, MI 48073, USA
    Gastroenterol Clin North Am 37:269-85, ix. 2008
    ..This article reviews these trials to illustrate key concepts, places these trials in perspective, and provides direction for future research...
  5. doi request reprint Generic planning target margin for rectal cancer treatment setup variation
    John M Robertson
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 74:1470-5. 2009
    ..To calculate the generic planning target margin (GPTM) for patients receiving radiation therapy (RT) for rectal cancer placed in a prone position with a customized cradle for small-bowel exclusion...
  6. doi request reprint Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma
    Jiayi Huang
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    Int J Radiat Oncol Biol Phys 83:1120-5. 2012
    ..To identify dosimetric predictors for the development of gastrointestinal (GI) toxicity in patients with locally advanced pancreatic adenocarcinoma (LAPC) treated with concurrent full-dose gemcitabine and radiotherapy (GemRT)...
  7. doi request reprint Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer
    Jiayi Huang
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, USA
    Radiother Oncol 99:114-9. 2011
    ..To retrospectively compare the efficacy and toxicity of full-dose gemcitabine based chemoradiotherapy (GemRT) versus 5-fluorouracil (5-FU) based chemoradiotherapy (5FURT) for locally advanced pancreas cancer (LAPC)...
  8. ncbi request reprint The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer
    Joost J Nuyttens
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    Cancer Radiother 8:297-304. 2004
    ....
  9. ncbi request reprint The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer
    Kathy L Baglan
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Int J Radiat Oncol Biol Phys 52:176-83. 2002
    ..This study uses three-dimensional treatment-planning tools to more precisely quantify this dose-volume relationship...
  10. doi request reprint Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine
    Andrew Baschnagel
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan 48072, USA
    Int J Radiat Oncol Biol Phys 83:e331-5. 2012
    ..To evaluate survival in patients with resected pancreatic cancer treated with concurrent chemoradiation with or without adjuvant gemcitabine (Gem)...
  11. ncbi request reprint Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine
    Aaron M Allen
    Department of Radiation Oncology, University of Michigan School of Medicine, 1500 E Medical Center Drive, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 59:1461-7. 2004
    ..To determine the maximal tolerated dose of radiation delivered to the primary tumor bed, in combination with full-dose gemcitabine (1000 mg/m(2) weekly x 3), after resection of pancreatic cancer...
  12. ncbi request reprint The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment
    Joost J Nuyttens
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    Int J Radiat Oncol Biol Phys 53:497-503. 2002
    ....
  13. doi request reprint Sorafenib and radiation: a promising combination in colorectal cancer
    Andrew W Suen
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA
    Int J Radiat Oncol Biol Phys 78:213-20. 2010
    ..To examine the combination of radiation and the multikinase inhibitor sorafenib in human colorectal cancer cell lines and xenografts...
  14. doi request reprint MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation
    Sean S Park
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Int J Radiat Oncol Biol Phys 80:885-92. 2011
    ....
  15. doi request reprint Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer
    Thomas B Lanni
    Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48072, USA
    Am J Clin Oncol 34:494-8. 2011
    ..We compare treatment outcomes and costs between SBRT and EBRT in this patient population...
  16. ncbi request reprint Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144
    Stephen R Smalley
    Kansas City Community Clinical Oncology Program CCOP, Kansas City, KS, USA
    J Clin Oncol 24:3542-7. 2006
    ..Adjuvant chemoradiotherapy after or before resection of high-risk rectal cancer improves overall survival (OS) and pelvic control. We studied three postoperative fluorouracil (FU) radiochemotherapy regimens...